12/05/2024 3:46 PM | CRAVES FRED B (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2024 3:16 PM | CRAVES FRED B (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/25/2024 3:10 PM | CRAVES FRED B (Reporting) Madrigal Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2024 3:30 PM | Huntsman Carole (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2024 3:30 PM | Huntsman Carole (Reporting) Madrigal Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024 4:18 PM | Madrigal Pharmaceuticals (Subject) PAULSON & CO. INC. (Filed by)
| Form SC 13G/A | |
11/14/2024 5:30 AM | Madrigal Pharmaceuticals (Subject) RTW INVESTMENTS, LP (Filed by)
| Form SC 13G | |
|
11/08/2024 4:07 PM | Levy Richard S (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/05/2024 6:01 PM | Levy Richard S (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2024 3:47 PM | Levy Richard S (Reporting) Madrigal Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024 3:32 PM | Madrigal Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/31/2024 8:02 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024 6:05 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/17/2024 7:36 PM | CRAVES FRED B (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2024 8:51 PM | Madrigal Pharmaceuticals (Issuer) Sibold William John (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/10/2024 8:29 PM | Madrigal Pharmaceuticals (Subject) Sibold William John (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024 7:16 PM | Kelley Shannon T (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2024 6:52 PM | Kelley Shannon T (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/07/2024 7:58 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024 6:06 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/27/2024 8:46 PM | CRAVES FRED B (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 8:41 PM | FRIEDMAN PAUL A (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 8:42 PM | Levy Richard S (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 8:42 PM | Daly James M (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 8:45 PM | BATE KENNETH (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 4:03 PM | 667, L.P. (Reporting) Baker Bros. Advisors LLC (0001580575) (Reporting) BAKER BROS. ADVISORS LP (Reporting) Baker Brothers Life Sciences LP (Reporting) BAKER FELIX (Reporting) BAKER JULIAN (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 3:28 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/18/2024 8:39 PM | Madrigal Pharmaceuticals (Issuer) Waltermire Robert E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 8:44 PM | Madrigal Pharmaceuticals (Issuer) Waltermire Robert E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:17 PM | Madrigal Pharmaceuticals (Subject) Waltermire Robert E. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024 3:37 PM | Lynch Brian Joseph (Reporting) Madrigal Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2024 8:45 PM | CRAVES FRED B (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 4:53 PM | Lynch Brian Joseph (Reporting) Madrigal Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024 4:03 PM | Madrigal Pharmaceuticals (Subject) Waltermire Robert E. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024 4:39 PM | Lynch Brian Joseph (Reporting) Madrigal Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2024 5:48 PM | Lynch Brian Joseph (Reporting) Madrigal Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024 8:36 PM | Madrigal Pharmaceuticals (Issuer) Waltermire Robert E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 8:53 PM | CRAVES FRED B (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 3:06 PM | Madrigal Pharmaceuticals (Filer)
| Form S-3ASR | |
05/07/2024 8:00 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024 6:06 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
04/29/2024 3:49 PM | Madrigal Pharmaceuticals (Filer)
| Form DEF 14A | |
04/10/2024 7:50 PM | FRIEDMAN PAUL A (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 7:53 PM | Madrigal Pharmaceuticals (Issuer) Taub Rebecca (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/05/2024 7:50 PM | FRIEDMAN PAUL A (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/05/2024 7:50 PM | Madrigal Pharmaceuticals (Issuer) Taub Rebecca (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 7:41 PM | Daly James M (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 7:44 PM | BATE KENNETH (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 7:47 PM | Levy Richard S (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 3:22 PM | Levy Richard S (Reporting) Madrigal Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024 3:21 PM | BAKER BROS. ADVISORS LP (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/25/2024 3:28 PM | BAKER BROS. ADVISORS LP (Filed by) Madrigal Pharmaceuticals (Subject)
| Form SC 13D/A | |
03/21/2024 3:30 PM | Dier Mardi (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/20/2024 3:11 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 6:10 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 6:01 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 5:32 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 1:50 PM | ARMISTICE CAPITAL, LLC (Filed by) Madrigal Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024 8:21 AM | Avoro Capital Advisors LLC (Filed by) Madrigal Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024 4:55 PM | JANUS HENDERSON GROUP PLC (Filed by) Madrigal Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/29/2024 4:25 PM | BlackRock Inc. (Filed by) Madrigal Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024 5:04 PM | Huntsman Carole (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 4:50 PM | Madrigal Pharmaceuticals (Issuer) Waltermire Robert E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 4:54 PM | Madrigal Pharmaceuticals (Issuer) Taub Rebecca (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 10:13 AM | Madrigal Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024 12:52 PM | Lynch Brian Joseph (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 12:39 PM | Howarth Alex G. (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 12:45 PM | Madrigal Pharmaceuticals (Issuer) Waltermire Robert E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 12:46 PM | Madrigal Pharmaceuticals (Issuer) Taub Rebecca (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 12:47 PM | FRIEDMAN PAUL A (Reporting) Madrigal Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 12:45 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |